A third COVID-19 vaccine dose may provide some hope for increased immunity for people with organ transplants, according to results of a small study published today in the

Most people can feel confident that COVID-19 vaccines will work as intended.   Not so for immunocompromised or immunosuppressed individuals; the current vaccines not were not designed or tested with them in mind.  

It’s not only sick patients who help researchers understand diseases.  In the 1990s, a rare genetic mutation in 1 man who seemed impervious to HIV proved key to creating antiretrovirals against the disease, opening up “a whole new realm of medical science.”  

Good news on reinfection front: US NIH researchers found that people with SARS-CoV-2 antibodies showed “substantial” immunity to the virus at least for a few months, 

Researchers want to make a global disease forecasting system that would be as easy as checking the weather.  

This is exciting news. The most robust study yet on COVID-19 immunity has found that it may last for years and perhaps decades.   The study by researchers at the La Jolla Institute of Immunology has not yet been peer reviewed, but it squares with similar findings from…

A landmark study of Ebola survivors could have big implications for COVID-19 research.  

The pandemic has upended research efforts across the world—how are institutions coping?   Brazil: Lacking government guidance, scientists working on COVID-19 vaccines and diagnostics implemented their own safety measures. They've canceled data collection…

It’s well known that infants and elderly people are particularly vulnerable to infectious diseases—but what happens in between those age extremes?  

The 25-year-old man from Washoe County, Nevada had classic symptoms of COVID-19 (sore throat, cough, headache…) when he got his first positive test on April 18, according to